Inga Liepelt-Scarfone
Overview
Explore the profile of Inga Liepelt-Scarfone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
2015
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Scharfenberg D, Kalbe E, Balzer-Geldsetzer M, Berg D, Hilker-Roggendorf R, Kassubek J, et al.
Alzheimers Dement (Amst)
. 2025 Feb;
17(1):e70091.
PMID: 39996032
Introduction: In neuropsychological diagnostics, the assignment of cognitive tests to domains is usually not empirically based. Hence, we aimed to assess the dimensionality structure of cognition in individuals with Parkinson's...
2.
Loenneker H, Artemenko C, Willmes K, Liepelt-Scarfone I, Nuerk H
J Neurosci Res
. 2024 Nov;
102(11):e25397.
PMID: 39548739
Neurodegenerative diseases such as Parkinson's disease (PD) have a huge impact on patients, caregivers, and the health care system. Until now, diagnosis of mild cognitive impairments in PD has been...
3.
Kalbe E, Folkerts A, Witt K, Buhmann C, Liepelt-Scarfone I
J Neurol
. 2024 Aug;
271(11):7330-7357.
PMID: 39120709
Background And Objective: Cognitive impairment and dementia as well as affective disorders are common and debilitating syndromes that develop in people with Parkinson's disease (PwPD). The authors summarized recommendations for...
4.
Weise D, Claus I, Dresel C, Kalbe E, Liepelt-Scarfone I, Lorenzl S, et al.
J Neural Transm (Vienna)
. 2024 Jul;
131(10):1217-1227.
PMID: 39039238
Parkinson's Disease (PD) is a multifaceted and progressive disorder characterized by a diverse range of motor and non-motor symptoms. The complexity of PD necessitates a multidisciplinary approach to manage both...
5.
Bode M, Kalbe E, Liepelt-Scarfone I
J Neural Transm (Vienna)
. 2024 Jul;
131(10):1159-1186.
PMID: 38976044
The ability to perform activities of daily living (ADL) function is a multifaceted construct that reflects functionality in different daily life situations. The loss of ADL function due to cognitive...
6.
Ophey A, Wirtz K, Wolfsgruber S, Balzer-Geldsetzer M, Berg D, Hilker-Roggendorf R, et al.
J Neurol
. 2024 Jul;
271(8):5411-5424.
PMID: 38951175
Background: Cognitive reserve (CR) is considered a protective factor for cognitive function and may explain interindividual differences of cognitive performance given similar levels of neurodegeneration, e.g., in Alzheimer´s disease. Recent...
7.
Roeben B, Liepelt-Scarfone I, Lerche S, Zimmermann M, Wurster I, Sunkel U, et al.
NPJ Parkinsons Dis
. 2024 Apr;
10(1):88.
PMID: 38649346
With disease-modifying treatment for Parkinson's disease (PD) associated with variants in the glucocerebrosidase gene (GBA1) under way, the challenge to design clinical trials with non-PD-manifest GBA mutation carriers (GBA1) comes...
8.
Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C, et al.
NPJ Parkinsons Dis
. 2024 Jan;
10(1):24.
PMID: 38242875
Seed amplification assays have been implemented in Parkinson's disease to reveal disease-specific misfolded alpha-synuclein aggregates in biospecimens. While the assays' qualitative dichotomous seeding response is valuable to stratify and enrich...
9.
Trenado C, Trauberg P, Elben S, Dimenshteyn K, Folkerts A, Witt K, et al.
Neurol Res Pract
. 2023 Sep;
5(1):46.
PMID: 37705108
Background: Cognitive decline is a major factor for the deterioration of the quality of life in patients suffering from Parkinson's disease (PD). Recently, it was reported that cognitive training (CT)...
10.
Bezdicek O, Ferreira J, Fellows R, Liepelt-Scarfone I
Front Aging Neurosci
. 2023 Apr;
15:1161736.
PMID: 37020860
No abstract available.